Twist Bioscience (TWST) Finished Goods (2018 - 2026)

Twist Bioscience (TWST) has reported Finished Goods for 9 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Finished Goods changed 0.06% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (changed 0.06% YoY), while the FY2025 annual figure was $5.9 million, up 26.8% from the prior year.
• Finished Goods fell to $5.0 million in Q1 2026 per TWST's latest filing, from $5.9 million in the prior quarter.
• Across five years, Finished Goods topped out at $9.6 million in Q1 2022 and bottomed at $3.9 million in Q3 2023.
• Historically, Finished Goods has averaged $5.9 million across 5 years, with a median of $5.3 million in 2023.
• Annual changes were most pronounced in 2022 — Finished Goods jumped 415.24% — and 2023, when it tumbled 48.71%.
• Twist Bioscience's Finished Goods stood at $7.4 million in 2022, then sank by 36.47% to $4.7 million in 2023, then advanced by 2.75% to $4.8 million in 2024, then gained by 22.43% to $5.9 million in 2025, then slipped by 15.41% to $5.0 million in 2026.
• Business Quant data shows TWST's Finished Goods at $5.0 million in Q1 2026, $5.9 million in Q4 2025, and $5.9 million in Q3 2025.